Inventor · disambiguated record
Simon Stamm
Also filed as: STAMM SIMON
13 granted patents·3 pending applications·38 citations·filing 2012–2023
86Inventor score
Files withIDORSIA PHARMACEUTICALS LTD8ACTELION PHARMACEUTICALS LTD4HILPERT KURT2PHOENIX CONTACT E MOBILITY GMBH2
Top patents by PatentIndex Score
16 records- 0187USD949797SConnector for electric vehiclePHOENIX CONTACT E MOBILITY GMBH·Filed 2020·Granted Apr 26, 2022·17 cites·1 claims
- 0285US10065929B2Pyrazole compounds and their use as T-type calcium channel blockersIDORSIA PHARMACEUTICALS LTD·Filed 2017·Granted Sep 4, 2018·5 cites·30 claims
- 0384US9932314B2Pyrazole compounds and their use as T-type calcium channel blockersIDORSIA PHARMACEUTICALS LTD·Filed 2015·Granted Apr 3, 2018·5 cites·28 claims
- 0482US10246426B2Triazole compounds as T-type calcium channel blockersIDORSIA PHARMACEUTICALS LTD·Filed 2015·Granted Apr 2, 2019·5 cites·13 claims
- 0580US9221832B2Heterocyclic amide derivatives as P2X7 receptor antagonistsHILPERT KURT·Filed 2012·Granted Dec 29, 2015·6 cites·14 claims
- 0668US2023192708A12,4,6,7-tetrahydro-pyrazolo[4,3-d]pyrimidin-5-one derivatives and related compounds as c5a receptor modulators for treating vasculitis and inflammatory diseasesIDORSIA PHARMACEUTICALS LTD·Filed 2022·Application pending·0 cites
- 0758US2024208342A1Plug connector part for a charging system for charging an electric vehiclePHOENIX CONTACT E MOBILITY GMBH·Filed 2023·Application pending·0 cites
- 0851US11608341B2Substituted tetrahydropyrazolo[3,4-d]pyrimidines and tetrahydropyrazolo[4,3-d]pyrimidines as C5A receptor modulatorsIDORSIA PHARMACEUTICALS LTD·Filed 2019·Granted Mar 21, 2023·0 cites·22 claims
- 0947US11685729B2C5a receptor modulatorsIDORSIA PHARMACEUTICALS LTD·Filed 2019·Granted Jun 27, 2023·0 cites·18 claims
- 1046US9388198B2Heterocyclic amide derivatives as P2X7 receptor antagonistsACTELION PHARMACEUTICALS LTD·Filed 2014·Granted Jul 12, 2016·0 cites·17 claims
- 1145US9388197B2Heterocyclic amide derivatives as P2X7 receptor antagonistsACTELION PHARMACEUTICALS LTD·Filed 2014·Granted Jul 12, 2016·0 cites·19 claims
- 1245US2022265658A1Pharmaceutical composition comprising a tetrahydropyrazolopyrimidinone compoundIDORSIA PHARMACEUTICALS LTD·Filed 2020·Application pending·0 cites
- 1344US9718774B2Indole carboxamide derivatives as P2X7 receptor antagonistACTELION PHARMACEUTICALS LTD·Filed 2013·Granted Aug 1, 2017·0 cites·19 claims
- 1444US9556117B2Indole carboxamide derivatives as P2X7 receptor antagonistsACTELION PHARMACEUTICALS LTD·Filed 2013·Granted Jan 31, 2017·0 cites·14 claims
- 1543US11739070B2C5A receptor modulatorsIDORSIA PHARMACEUTICALS LTD·Filed 2019·Granted Aug 29, 2023·0 cites·16 claims
- 1640US9409917B2Heterocyclic amide derivatives as P2X7 receptor antagonistsHILPERT KURT·Filed 2013·Granted Aug 9, 2016·0 cites·16 claims
Join the waitlist — get patent alerts
Get an alert when Simon Stamm files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →